13F filer · CIK 1744967
SAMSARA BIOCAPITAL, LLC
PALO ALTO, CA · filing since Q4 2018 · last filing Aug 14, 2026
Reported value
$1.2B
+$188.4M vs prior
Positions
24
New / sold out
4 / 2
Added / reduced
2 / 5
Turnover
2.0%
buys $102.9M · sells $22.1M
Top-10 weight
90.5%
Biggest buys vs Q1 2026
| Change | Security | Shares change | Change % | Est. trade value |
|---|---|---|---|---|
| New | ALAMAR BIOSCIENCES INC | +2,480,310 | – | +$67.2M |
| New | PARABILIS MEDICINES INC | +556,044 | – | +$15.2M |
| New | ARTIVA BIOTHERAPEUTICS INC | +954,861 | – | +$9.3M |
| New | ELOXX PHARMACEUTICALS INC | +400,000 | – | +$5.6M |
| Added | INVENTIVA SA | +1,120,000 | +21.6% | +$4.2M |
| Added | RANI THERAPEUTICS HLDGS INC | +1,869,159 | +22.0% | +$1.4M |
Biggest sells vs Q1 2026
| Change | Security | Shares change | Change % | Est. trade value |
|---|---|---|---|---|
| Sold out | ARCELLX INC | -60,873 | -100.0% | $-7.0M |
| Reduced | JADE BIOSCIENCES INC | -232,561 | -24.0% | $-5.2M |
| Sold out | PALVELLA THERAPEUTICS INC NE | -38,432 | -100.0% | $-4.8M |
| Reduced | UPSTREAM BIO INC | -382,330 | -51.9% | $-2.6M |
| Reduced | X4 PHARMACEUTICALS INC | -436,979 | -23.8% | $-2.0M |
| Reduced | KALARIS THERAPEUTICS INC | -66,906 | -0.5% | $-272.3K |
| Reduced | ABIVAX SA | -1,486 | -2.6% | $-198.0K |
Estimated trade value = change in shares × this quarter's implied price. 13F filings show quarter-end positions, not individual trades.
Reported value by quarter
Holdings · Q2 2026
| # | Security | Shares | Value | Weight |
|---|---|---|---|---|
| 1 | SCHOLAR ROCK HLDG CORPCOM | 6,897,652 | $379.4M | 31.16% |
| 2 | ALUMIS INCCOM | 6,345,219 | $178.6M | 14.67% |
| 3 | MINERALYS THERAPEUTICS INCCOM | 5,871,018 | $158.4M | 13.01% |
| 4 | SEPTERNA INCCOM | 3,149,128 | $105.5M | 8.66% |
| 5 | ALAMAR BIOSCIENCES INCCOMMON STOCK | 2,480,310 | $67.2M | 5.52% |
| 6 | NEUROGENE INCCOM | 1,717,127 | $54.0M | 4.44% |
| 7 | KALARIS THERAPEUTICS INCCOM | 12,881,175 | $52.4M | 4.31% |
| 8 | SPYGLASS PHARMA INCCOM SHS | 2,109,953 | $47.0M | 3.86% |
| 9 | SUTRO BIOPHARMA INCCOM SHS | 1,062,872 | $35.3M | 2.90% |
| 10 | INVENTIVA SAADS | 6,314,805 | $23.9M | 1.96% |
14 more rows. Subscribe for $29/month to see every row, download the data and use the API.